Global Bioinformatics Platforms Market Growth (Status and Outlook) 2025-2031

According to this study, the global Bioinformatics Platforms market size will reach US$ 1043 million by 2031.

Bioinformatics platform combines statistical analysis modules to enable faster and easier analysis and integration and visualization of different types of big data generated through analysis of microbial genomes. Various bioinformatics tools for comparative analyses on gene level have been developed such as IMG/M, MicrobesOnline, MBGD, Roary, and EDGAR.

United States market for Bioinformatics Platforms is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Bioinformatics Platforms is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Bioinformatics Platforms is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Bioinformatics Platforms players cover Affymetrix, Dassault Systemes, Agilent Technologies, QIAGEN, ID Business Solutions, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Bioinformatics Platforms Industry Forecast” looks at past sales and reviews total world Bioinformatics Platforms sales in 2024, providing a comprehensive analysis by region and market sector of projected Bioinformatics Platforms sales for 2025 through 2031. With Bioinformatics Platforms sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bioinformatics Platforms industry.

This Insight Report provides a comprehensive analysis of the global Bioinformatics Platforms landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Bioinformatics Platforms portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bioinformatics Platforms market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bioinformatics Platforms and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bioinformatics Platforms.

This report presents a comprehensive overview, market shares, and growth opportunities of Bioinformatics Platforms market by product type, application, key players and key regions and countries.

Segmentation by Type:
Sequence Analysis Platforms
Sequence Alignment Platforms
Sequence Manipulation Platforms
Structural & Functional Analysis Platforms
Others

Segmentation by Application:
Drug Development
Molecular Genomics
Personalized Medicine
Gene Therapy
Protein Function Analysis
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Affymetrix
Dassault Systemes
Agilent Technologies
QIAGEN
ID Business Solutions
GenoLogics Life Sciences
Illumina

Please note: The report will take approximately 2 business days to prepare and deliver. Show more